Revolutionizing the Manufacturing of ADCs – A Conversation with ADC Bio’s Charlie Johnson.

In this edition of The Onco’Zine Brief Peter Hofland talks with, Charlie Johnson, Chief Executive Officer of ADC Bio, about the manufacturing of ADCs, including the complexities of the typical supply chain.

This interview was originally recorded during CPhI worldwide, the pharmaceutical industry meeting, held October 9 – 11, 2018 in Madrid, Spain. This edition was a co-production with ADC Review | the Journal of Antibody-drug Conjugates and OncoZine.

Listen Now.